India's Ind-Swift Laboratories Ltd. appointed Poonam Maini an independent director of the company.
Ind-Swift develops active pharmaceutical ingredients, which are used in the manufacturing of medicines.
Ind-Swift Laboratories adds independent director
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
India's Ind-Swift Laboratories Ltd. appointed Poonam Maini an independent director of the company.
Ind-Swift develops active pharmaceutical ingredients, which are used in the manufacturing of medicines.